Li Chengjian, Zamore Phillip D
Cold Spring Harb Protoc. 2018 Feb 1;2018(2):2018/2/pdb.prot097527. doi: 10.1101/pdb.prot097527.
This protocol is used to design antisense oligonucleotides (ASOs) for specific inhibition of miRNA function in cultured cells. The incorporation of 2'--methyl-modifications in ASOs enhances their potency and resistance to degradation, whereas 3'-terminal cholesterol-conjugation facilitates delivery of ASOs into cells.